Diabetic myonecrosis complicated by emphysematous pyomyositis and abscess caused by Escherichia coli: a case report.

Autor: Kerola AM; Department of Rheumatology, Inflammation Center, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland. anne.kerola@helsinki.fi., Eklund KK; Department of Rheumatology, Inflammation Center, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland., Valleala H; Department of Rheumatology, Inflammation Center, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland., Tynninen O; Department of Pathology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Helve J; Department of Nephrology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Haapamäki V; Radiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Eriksson M; Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Journal of medical case reports [J Med Case Rep] 2024 Jul 01; Vol. 18 (1), pp. 300. Date of Electronic Publication: 2024 Jul 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Autor: Hiltunen J; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland. johanna.hiltunen@hus.fi., Parmanne P; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Sokka T; Department of Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.; University of Eastern Finland, Kuopio, Finland., Lamberg T; United Medix Laboratories, Helsinki, Finland., Isomäki P; Department of Rheumatology, Tampere University Hospital, Tampere, Finland., Kaipiainen-Seppänen O; Department of Rheumatology, Kuopio University Hospital, Kuopio, Finland., Peltomaa R; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Uutela T; Department of Rheumatology, Central Hospital of Lapland, Rovaniemi, Finland., Pirilä L; Department of Rheumatology, Turku University Hospital, Turku, Finland., Taimen K; Department of Rheumatology, Turku University Hospital, Turku, Finland., Kauppi MJ; Department of Rheumatology, Päijät-Häme Central Hospital, Lahti, Finland.; University of Tampere, Tampere, Finland., Yli-Kerttula T; Department of Rheumatology, Satakunta Central Hospital, Rauma, Finland., Tuompo R; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Relas H; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Kortelainen S; Department of Rheumatology, Turku University Hospital, Turku, Finland., Paalanen K; Department of Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.; University of Eastern Finland, Kuopio, Finland., Asikainen J; Department of Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.; University of Eastern Finland, Kuopio, Finland., Ekman P; Department of Rheumatology, Satakunta Central Hospital, Rauma, Finland., Santisteban A; Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland., Vidqvist KL; Department of Rheumatology, Tampere University Hospital, Tampere, Finland., Tadesse K; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Romu M; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Borodina J; Department of Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.; University of Eastern Finland, Kuopio, Finland., Elfving P; Department of Rheumatology, Kuopio University Hospital, Kuopio, Finland., Valleala H; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Leirisalo-Repo M; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland., Rantalaiho V; Department of Rheumatology, Tampere University Hospital, Tampere, Finland., Kautiainen H; Medcare Foundation, Äänekoski, Finland., Jokiranta TS; SYNLAB Finland, Helsinki, Finland., Eklund KK; Department of Rheumatology, Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, P. O. Box 372, 00029 HUS, Helsinki, Finland.; Translational Immunology Research Program, Helsinki University and Orton Research Foundation, Orton Hospital, Helsinki, Finland.

Publikováno v: Rheumatology international [Rheumatol Int] 2022 Jun; Vol. 42 (6), pp. 1015-1025. Date of Electronic Publication: 2021 Aug 06.

Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.

Autor: Valleala, H¹ (AUTHOR) heikki.valleala@hus.fi, Korpela, M² (AUTHOR), Möttönen, T³ (AUTHOR), Hienonen-Kempas, T⁴ (AUTHOR), Kauppi, M⁵ (AUTHOR), Hannonen, P⁶ (AUTHOR), Leirisalo-Repo, M¹ (AUTHOR)

Publikováno v: Scandinavian Journal of Rheumatology. Oct2009, Vol. 38 Issue 5, p323-327. 5p. 1 Diagram, 1 Chart, 1 Graph.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.